These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 5-HT1A receptor-effector system responsivity in panic disorder. Lesch KP; Wiesmann M; Hoh A; Müller T; Disselkamp-Tietze J; Osterheider M; Schulte HM Psychopharmacology (Berl); 1992; 106(1):111-7. PubMed ID: 1346719 [TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Wiesmann M; Osterheider M; Schulte HM Biol Psychiatry; 1990 Oct; 28(7):620-8. PubMed ID: 1977479 [TBL] [Abstract][Full Text] [Related]
5. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974 [TBL] [Abstract][Full Text] [Related]
6. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects. Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479 [TBL] [Abstract][Full Text] [Related]
7. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797 [TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Lerer B; Gelfin Y; Gorfine M; Allolio B; Lesch KP; Newman ME Neuropsychopharmacology; 1999 Jun; 20(6):628-39. PubMed ID: 10327431 [TBL] [Abstract][Full Text] [Related]
9. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Schoellnhammer G; Schulte HM Life Sci; 1990; 46(18):1271-7. PubMed ID: 1971701 [TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. Lesch KP; Hoh A; Disselkamp-Tietze J; Wiesmann M; Osterheider M; Schulte HM Arch Gen Psychiatry; 1991 Jun; 48(6):540-7. PubMed ID: 1674853 [TBL] [Abstract][Full Text] [Related]
11. The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids. Lesch KP; Lerer B J Neural Transm Gen Sect; 1991; 84(1-2):3-18. PubMed ID: 1647169 [TBL] [Abstract][Full Text] [Related]
12. 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Cowen PJ; Power AC; Ware CJ; Anderson IM Br J Psychiatry; 1994 Mar; 164(3):372-9. PubMed ID: 8199791 [TBL] [Abstract][Full Text] [Related]
13. Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy. Shapira B; Newman ME; Gelfin Y; Lerer B Psychoneuroendocrinology; 2000 Jul; 25(5):421-38. PubMed ID: 10818278 [TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptor function in depression: effect of chronic amitriptyline treatment. Lesch KP; Disselkamp-Tietze J; Schmidtke A J Neural Transm Gen Sect; 1990; 80(2):157-61. PubMed ID: 2317317 [TBL] [Abstract][Full Text] [Related]
15. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone. Shiah IS; Yatham LN; Lam RW; Zis AP Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426 [TBL] [Abstract][Full Text] [Related]
16. Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. Lesch KP; Söhnle K; Poten B; Schoellnhammer G; Rupprecht R; Schulte HM J Clin Endocrinol Metab; 1990 Mar; 70(3):670-4. PubMed ID: 1968468 [TBL] [Abstract][Full Text] [Related]
17. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956 [TBL] [Abstract][Full Text] [Related]
18. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects. Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749 [TBL] [Abstract][Full Text] [Related]
19. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374 [TBL] [Abstract][Full Text] [Related]
20. Is there a role for 5-HT1A agonists in the treatment of depression? Blier P; Ward NM Biol Psychiatry; 2003 Feb; 53(3):193-203. PubMed ID: 12559651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]